Market Research Logo

Anti-Infectives: World Market, 2nd Edition, Vol III: Antivirals

This third volume of Kalorama Information’s World Market for Anti-Infectives series, the 2nd. Edition focuses on three general product segments of antiviral treatment:

  • Nucleoside Analogs
  • Protease Inhibitors
  • Other Misc. Antivirals
The report covers both currently marketed and late stage development antiviral products in detail. For each segment, the report provides:
  • Revenue Data by Infection Type
  • An overview of products on the market
  • Review of products in the development pipeline
  • Market estimates and forecasts through 2011
  • Market segmentation by geographic region
  • Market share of leading suppliers
  • Market share of leading products
The report also includes statistical (epidemiologic and demographic) information for viral infections by type worldwide, with special emphasis on the United States and describes the major clinical, business, and regulatory trends shaping the global and domestic markets.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. In addition, Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level as of 2006. Compound annual growth rates (CAGRs) are provided for 2006-2011 periods for each industry segment covered. Competitive analysis is provided for the year 2006. The forecasted market analysis for 2006-2011 was based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.


  • Executive Summary
    • INTRODUCTION
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
      • Table The World Market for Antiviral Drugs 2004-2011
    • ISSUES AND TRENDS AFFECTING MARKET
    • LEADING COMPETITORS
  • Introduction
    • INTRODUCTION TO VIRUSES
      • Examples of Pathogenic Viruses
    • VIRUS FUNCTION AND LIFE HISTORY
      • Replication in DNA Viruses
      • Replication of RNA Viruses
      • Replication in Retroviruses
        • Table Host Cell Receptors
    • HOST DEFENSES AGAINST VIRUSES
    • VIRAL PLOYS TO INVADE HOST CELLS AND CIRCUMVENT HOST RESPONSES
      • Invasion of Host Cells
      • Subversion of the Immune Response
      • Avoidance of Immune Detection and Attack by Killer Cells
    • HIV AND AIDS
    • DEMOGRAPHICS AND STATISTICS
      • Table Estimated World and U.S. Incidence of Viral Infections
      • Table World Population by Selected Geographical Region, 2006-2050
      • Table Estimated World Population by Age and Geographical Region, 2006
  • Nucleoside Analogs, Transcriptase Inhibitors and DNA Polymerase Inhibitors
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Nucleoside Reverse Transcriptase Inhibitors
        • Table Currently Available Nucleoside Reverse Transcriptase Inhibitors (Type, Brand, and Manufacturer)
      • Combination Nucleoside Reverse Transcriptase Inhibitors
        • Table Currently Available Combination Nucleoside Reverse Transcriptase Inhibitors (Type, Brand, and Manufacturer)
      • Nucleotide Analogue Reverse Transcriptase Inhibitors
        • Table Currently Available Nucleotide Analog Reverse Transcriptase Inhibitors (Type, Brand, and Manufacturer)
      • Non-Nucleoside Reverse Transcriptase Inhibitors
        • Table Currently Available Non-Nucleoside Reverse Transcriptase Inhibitors (Type, Brand, and Manufacturer)
      • Combination Non-Nucleoside Reverse Transcriptase Inhibitors
        • Table Currently Available Combination Non-Nucleoside Reverse Transcriptase Inhibitors (Type, Brand, and Manufacturer)
      • DNA Polymerase Inhibitors
        • Table Currently Available DNA Polymerase Inhibitors (Type, Brand, and Manufacturer)
    • GENERIC DRUG IMPACT AND AVAILABILITY
      • Table New Generic Drug Approvals for Nucleoside Analogs, Transcriptase Inhibitors, and DNA Polymerase Inhibitors, United States, 2005-2006
    • RESEARCH AND DEVELOPMENT
      • Table Nucleoside Analogs, Transcriptase Inhibitors and DNA Polymerase Inhibitors In Development
    • MARKET SIZE AND GROWTH
      • Table The Market for Nucleoside Analogs, Transcriptase Inhibitors and DNA Polymerase Inhibitor 2004-2011
      • Table Nucleoside Analog, Transcriptase Inhibitors and DNA Polymerase Inhibitor Market Estimated Products Sales by Infection Type, 2006
      • Table Nucleoside Analog, Transcriptase Inhibitors and DNA Polymerase Inhibitor Market Estimated Products Sales by Geographic Region, 2006
    • COMPETITIVE ANALYSIS
      • Table Nucleoside Analog, Transcriptase Inhibitors and DNA Polymerase Inhibitor Market Estimated Revenues and Market Share of Leading Suppliers 2006
      • Table Nucleoside Analog, Transcriptase Inhibitors and DNA Polymerase Inhibitor Market Projected Revenues and Market Share of Leading Suppliers 2011
      • Table Nucleoside Analog, Transcriptase Inhibitors and DNA Polymerase Inhibitor Market Estimated Sales of Top Nucleoside Analogs, Transcriptase Inhibitors and DNA Polymerase Inhibitors 2006
  • Protease Inhibitors
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Protease Inhibitors
        • Table Currently Available Protease Inhibitors (Type, Brand, and Manufacturer)
      • Combination Protease Inhibitors
        • Table Currently Available Combination Protease Inhibitors (Type, Brand, and Manufacturer)
    • RESEARCH AND DEVELOPMENT
      • Table Protease Inhibitors in Development
    • MARKET SIZE AND GROWTH
      • Table The Market for Protease Inhibitors 2004-2011
      • Table Protease Inhibitor Market Estimated Products Sales by Geographic Region, 2006
    • COMPETITIVE ANALYSIS
      • Table Protease Inhibitor Market Estimated Revenues and Market Share of Leading Suppliers 2006
      • Table Protease Inhibitor Market Projected Revenues and Market Share of Leading Suppliers 2011
      • Table Protease Inhibitor Market Projected Market Share by Leading Suppliers 2011
      • Table Protease Inhibitor Market Estimated Sales of Top Protease Inhibitors 2006
  • Other Antivirals
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Immune Response Modifiers
        • Table Currently Available Antiviral Immune Response Modifiers (Type, Brand, and Manufacturer)
      • Immunoglobulin G
        • Table Currently Available Immunoglobulin G Products (Type, Brand, and Manufacturer)
      • Adamantane Derivatives
        • Table Currently Available Adamantane Derivatives (Type, Brand, and Manufacturer)
      • Fusion Inhibitors
        • Table Currently Available Fusion Inhibitors (Type, Brand, and Manufacturer)
      • Interferons
        • Table Currently Available Interferons (Type, Brand, and Manufacturer)
      • Neuraminidase Inhibitors
        • Table Currently Available Neuraminidase Inhibitors (Type, Brand, and Manufacturer)
      • Immunizing Agents
        • Table Currently Available Immunizing Agents (Type, Brand, and Manufacturer)
      • Monoclonal Antibodies
        • Table Currently Available Monoclonal Antibodies (Type, Brand, and Manufacturer)
      • Miscellaneous Antivirals
        • Table Miscellaneous Antivirals (Type, Brand, and Manufacturer)
    • GENERIC DRUG IMPACT AND AVAILABILITY
      • Table New Generic Drug Approvals for Other Antivirals, United States, 2005-2006
    • RESEARCH AND DEVELOPMENT
      • Table Other Antivirals in Development
    • MARKET SIZE AND GROWTH
      • Table The Market for Other Antivirals 2004-2011
      • Table Other Antiviral Market Estimated Products Sales by Infection Type, 2006
      • Table Other Antiviral Market Estimated Products Sales by Geographic Region, 2006
    • COMPETITIVE ANALYSIS
      • Table Other Antiviral Market Estimated Revenues and Market Share of Leading Suppliers 2006
      • Table Other Antiviral Market Projected Revenues and Market Share of Leading Suppliers 2011
      • Table Other Antiviral Market Estimated Sales of Other Antiviral Products 2006
  • Issues and Trends Affecting the Antiviral Market
    • INTRODUCTION
    • ANTIVIRAL DRUG RESISTANCE
    • MEDICARE PART D
    • HIV DRUG COST CONTROVERSY
    • ANTIRETROVIRAL TREATMENT REGIMENS
    • HIV AND WOMEN
      • Table People Living with HIV/AIDS by Region
    • GLOBAL SURVEILLANCE
    • MATURATION INHIBITOR DEVELOPMENT
    • BIOCHEMICAL PREVENTION AND TREATMENT OF VIRAL INFECTIONS
    • COSTS AND FUNDING OF HIV TREATMENT
      • Table AIDS Resource Needs (USS billion)
    • ACCESS TO HIV/AIDS TREATMENT
      • Table Access Needs of Adults and Children with HIV by Regions
      • Table Antiretroviral Access for HIV Infected Individuals by Region
  • Antiviral Drugs: Total Market Size and Forecast
    • OVERVIEW
    • TOTAL MARKET SIZE AND FORECAST
      • Table The World Market for Antiviral Drugs 2004-2011
      • Table Antiviral Drug Market by Type 2004-2011
      • Table The World Market for Antiviral Drugs Revenues by Type 2006 and 2011
  • Corporate Profiles
    • INTRODUCTION
    • ABBOTT LABORATORIES
    • BOEHRINGER INGELHEIM GMBH
    • BRISTOL-MYERS SQUIBB COMPANY
    • GILEAD SCIENCES, INC.
    • GLAXOSMITHKLINE
    • MEDIMMUNE, INC.
    • MERCK & COMPANY, INC.
    • NOVARTIS PHARMACEUTICALS CORPORATION
    • ROCHE
    • SCHERING-PLOUGH CORPORATION
  • Company Names and Addresses

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report